There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biohaven Ltd. (BHVN – Research Report), Becton Dickinson (BDX – Research Report) and Edgewise Therapeutics (EWTX – Research Report) with bullish sentiments.
Biohaven Ltd. (BHVN)
Piper Sandler analyst Christopher Raymond maintained a Buy rating on Biohaven Ltd. today and set a price target of $66.00. The company’s shares closed last Monday at $38.33.
According to TipRanks.com, Raymond is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Biohaven Ltd. with a $60.14 average price target, implying a 51.5% upside from current levels. In a report issued on April 9, RBC Capital also maintained a Buy rating on the stock with a $61.00 price target.
See the top stocks recommended by analysts >>
Becton Dickinson (BDX)
Piper Sandler analyst Jason Bednar maintained a Buy rating on Becton Dickinson today and set a price target of $280.00. The company’s shares closed last Monday at $233.88, close to its 52-week low of $229.40.
According to TipRanks.com, Bednar ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Becton Dickinson with a $288.71 average price target, which is a 23.0% upside from current levels. In a report issued on April 8, Argus Research also maintained a Buy rating on the stock with a $300.00 price target.
Edgewise Therapeutics (EWTX)
In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Edgewise Therapeutics, with a price target of $48.00. The company’s shares closed last Monday at $15.08.
According to TipRanks.com, Rahimi is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Edgewise Therapeutics with a $35.33 average price target, representing a 121.8% upside. In a report issued on April 16, Wedbush also maintained a Buy rating on the stock with a $26.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BHVN:
